EBIT: Income before interest and taxes.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) had EBIT of $-11.92M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-11.72M |
|
-- |
|
-- |
|
$11.92M |
|
$-11.92M |
|
$0.20M |
|
$-11.72M |
|
$-11.72M |
|
$-11.72M |
|
$-11.72M |
|
$-11.72M |
|
$-11.72M |
|
|
EBIT |
$-11.92M |
$-11.56M |
|
0.16M |
|
0.16M |
|
$-71.60 |
|
$-71.60 |
|
| Balance Sheet Financials | |
$0.50M |
|
$0.02M |
|
$9.97M |
|
$10.48M |
|
$7.97M |
|
-- |
|
$0.25M |
|
$8.22M |
|
$2.25M |
|
$-7.59M |
|
$2.25M |
|
0.20M |
|
| Cash Flow Statement Financials | |
$-9.48M |
|
$-3.06M |
|
$10.95M |
|
$1.92M |
|
$0.33M |
|
$-1.59M |
|
$0.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-519.94% |
|
154.50% |
|
-111.89% |
|
-519.94% |
|
$11.14 |
|
$-57.96 |
|
$-57.89 |
|